Key points are not available for this paper at this time.
In vivo modeling with loss of CBX2 expression and Nanostring pathway analysis
Iwanaga et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: